Mycophenolate mofetil and atopic dermatitis: systematic review and meta-analysis
Authors:
- 1 August 2019
- journal article
- review article
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 31 (8) , 810-814
Abstract
Background: For severe cases of atopic dermatitis, systemic or potent agents may be required for control of disease. There have been some reports of treatment efficacy of off-label use of mycophenolate mofetil (MMF) in patients with refractory atopic dermatitis or have developed adverse effects to initial systemic agents. Methods: Electronic searches were performed using six databases from their inception to April 2019. Data were extracted and analyzed according to predefined clinical endpoints. Results: From 140 cases, the mean age was 38.21 ± 22.8 years. There were 52.9% males and 47.1% females. The average number of failed agents was 3.5 ± 1.2. 77.6% reported partial or full remission. Relapses occurred in 8.2% of cases. The average time for initial effects was 6.8 ± 7 weeks. There was a significant reduction in pre to post SCORAD scores by 18 points (p = .0002). More males had complications compared to females. Prolonged duration of treatment ≥1 year was associated with herpes infections. Conclusions: In summary, the current evidence to date is low-quality in nature but is promising regarding the efficacy and safety of MMF for adult and pediatric atopic dermatitis. There should be ongoing monitoring for infections that may develop on long term therapy.Keywords
This publication has 33 references indexed in Scilit:
- Systemic Treatment of Pediatric Atopic Dermatitis with Azathioprine and Mycophenolate MofetilPediatric Dermatology, 2011
- Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: A randomized controlled trialJournal of the American Academy of Dermatology, 2011
- Tratamiento de la dermatitis atópica grave del adulto con mofetil micofenolato en 8 pacientesActas Dermo-Sifiliograficas, 2009
- First experience with enteric-coated mycophenolate sodium (Myfortic®) in severe recalcitrant adult atopic dermatitis: an open label studyBritish Journal of Dermatology, 2009
- Mycophenolate mofetil for severe childhood atopic dermatitis: experience in 14 patientsBritish Journal of Dermatology, 2007
- Cyclosporin in the treatment of patients with atopic eczema – a systematic review and meta‐analysisJournal of the European Academy of Dermatology and Venereology, 2007
- Gender-Related Differences in Mycophenolate Mofetil-Induced Gastrointestinal Toxicity in RatsDrug Metabolism and Disposition, 2007
- Mycophenolate Mofetil Therapy for Inflammatory Eye DiseaseOphthalmology, 2005
- Treatment of Linear IgA Bullous Dermatosis of Childhood With Mycophenolate MofetilArchives of Dermatology, 2003
- Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitisThe Lancet, 1991